: [66][67][68][69] Little health economics research has been done in developing countries, reflecting the fact that 10% of the world's health research is devoted to 90% of the world's health problems. Healthcare in developing countries relies more on market mechanisms than healthcare in developed countries. From a health economist's point of view, there are reasons to suspect that healthcare systems in many developing countries are both inefficient and inequitable. The public healthcare model in Europe offers better solutions to the problems in developing countries than the private health care model in the USA. In this article aspects of the health economics situation in Vietnam are discussed and some important health economics research questions identified.
INTRODUCTION
It is important to observe the relationship between the health of a nation, the healthcare system, and its economic and political situation. Levels of economic development as well as implemented policies affect incidence of diseases and injuries, ways in which healthcare can be financed, ownership and management of hospitals, how much physicians are paid and how they are paid, and what medical technologies and pharmaceuticals are used and for whom. These questions are a small section of the health economics field. Since the 1960s health economics has grown rapidly in Europe and North America but unfortunately there are still very few studies from developing countries, despite the fact that there the gap between available resources and people's need of healthcare is widest. Particularly in situations with extremely limited resources and extensive health problems, health economics can make a valuable contribution to policy making. This paper is devoted to discussing the potential of health economics research in Vietnam, where much of the current situation is typical for developing countries.
One starting point for research within the healthcare system could be the simple model shown in Figure 1 . Such a system consists in principle of three elements. Citizens or patients have to finance healthcare through taxes, insurance premiums, or outof-pocket payments. As a consequence, they can expect to receive the benefits of insurance and healthcare. Taxes and insurance premiums are paid in advance to a government agency or an insurance company, which then reimburse healthcare providers in respect of healthcare utilization.
The current situation in Vietnam reflects substantial changes over the last decade. Until the renovation period (''Doi Moi'' was initiated 1986) Vietnam had a central planned economy. The renovation of the economy resulted in privatization of the agricultural sector, extensive investments in infrastructure, and market determination of prices and wages, followed by high inflation rates. For the healthcare sector, one impact of the economic transition was the Government's inability to finance the existing system. Before Doi Moi Vietnam had a public and centrally planned healthcare system which was free of charge for patients. Commune health centres were financed by local agricultural cooperatives, but when that system came to an end financial difficulties appeared. For hospitals the main financial sources were state tax and foreign aid, but the latter declined rapidly when the former Soviet Union collapsed. As a response to these financial problems, user fees were introduced and private practice was legalized and encouraged. Today, around 70 -80% of financing is through out-of-pocket payment. Social insurance was introduced but has so far had limited impact and growth in Vietnam. About 12% of the population had compulsory insurance by 1997 and about 5% had voluntary insurance (2) .
How cost effective have these developments been? One important school in health economics assumes that the goal in the healthcare sector is to optimize the health of the population within the resources available (known as ''extra welfarism''). Health is preferably assessed by some subjective measurement unit such as Quality Adjusted Life Years (QALYs). Thus costeffectiveness is achieved when the largest possible number of QALYs is produced in relation to the amount of resources available. Using this theory, what can we conclude about cost-effectiveness in healthcare systems in developing countries? One point of departure is the fact that healthcare resources are almost the same as drugs in many countries. As much as 80% of healthcare resources in Vietnam are deployed on drugs, as compared with 15% in Sweden in 2000 (3). Furthermore a high proportion of the drugs in Vietnam are sold without prescription in small private pharmacies. The staff are poorly educated and the owners' profits increase with volume sold. Both regulations and supervision are in general weak. Chuc et al. have shown a wide gap between good practice and actuality in pharmacies in Hanoi (4). These kinds of markets for drug shopping are probably a very ineffective use of resources, meaning that the health gain per dollar used is comparatively low. One reason for that allegation is the information asymmetry in healthcare, described in 1963 by the Nobel Prize winner J K Arrow:
Because medical knowledge is so complicated, the information possessed by the physician as to the consequences and possibilities of treatment is necessarily very much greater than that of the patient, or at least so it is believed by both parties. (5) Arrow's conclusion in this landmark paper was:
It is the general social consensus, clearly, that the laissez-faire solution for medicine is intolerable. (5) Without considering costs, there is a technical relationship between drugs and health. The ''right'' drug in the appropriate dose to the ''right'' patient can improve both length and quality of life. However, there are no reasons to believe that an optimal match between patients and different drugs can be achieved by drug shopping. Rather, the extension of under-use, for example of drugs for the treatment of tuberculosis (6) , and of over-use, for example of antibiotics (7) , is likely to lead to significant loss of potential health gains and directly affect health adversely.
Taking costs into account, the choice between drugs and other measures must be considered. Suppose that the risk for cardiovascular disease can be reduced by 10% either by using a hypertension drug, with no side effects, or by the patient quitting smoking as a result of advice from a nurse. Thus we have two different interventions achieving identical results in terms of changed risk. The choice between the two measures depends on the relative prices of the two production factors involved: a hypertension drug and nurse time. The cost for drug treatment during one year can be expressed as the amount of nurse time we can buy for that sum. The number of working hours equivalent to a drug package varies considerably between developing and developed countries and is much higher in the former because of low wage levels. Therefore it generally seems wise to develop more non-pharmaceuticalbased prevention programmes in developing countries.
The brief observations presented here underpin a hypothesis that existing systems are not cost-effective. A redistribution of resources from out-of-pocket payments for drugs without prescription to professional diagnostics and counselling measures would probably increase the amount of QALYs gained by the resources currently employed in Vietnamese healthcare.
We also need to consider whether health systems are equitable. A citizen or patient has two relations to the system (Figure 1) , both as the financer and as the user of healthcare, and both these roles can be assessed in equity terms. Starting with the financing relation, about 70 -80% of healthcare in Vietnam is financed by out-of-pocket payments. The financial contribution to the healthcare system from different income groups has been studied frequently, and the main message from those studies is that the Vietnamese system is regressive, that is the lower income groups deploy a larger fraction of their income for healthcare than those with higher income. In a recent study, Thuan (8) showed that household healthcare expenditure was 5.0% in the group with the highest income and 8.4% in the group with the lowest income. Considering the fact that the income was three times larger in the ''high-income'' group, it is obvious that they can afford both more and better healthcare. However, the average proportion paid in different income classes is only one side of the coin, because the randomness of disease and injury makes it highly likely that people in the same income group will pay very different amounts. People free from disease and injury will pay nothing while those unfortunate enough to be affected by catastrophic illness have to pay enormous amounts. In another article in this Supplement, Thanh et al. (9) have estimated the economic burden of unintentional injuries in Bavi, Vietnam. One of the most striking results is that the cost to the household following a severe injury is equivalent to the income from about eight months' work. Victims and their families are likely to meet large difficulties in everyday life over several years as a result of such an injury. Some people are thus unable to receive appropriate care and others try to finance expensive care through loans or by selling valuable assets.
Studies of equity in healthcare require that persons or households are divided into socioeconomic groups. This classification is a research area in itself, and Khe et al. (10) have, in an article in this Supplement, investigated the sensitivity and specificity of some socioeconomic measures as applied to the population in Bavi. Five economic indicators were included in the study: income, expenditure, household assets, housing conditions, and local authority's estimation. The authors concluded:
Our results show that no indicator is particularly useful to predict the values of any other indicator and different poverty indicators may classify different socioeconomic groups as poor. (10) In Europe, we may consider whether healthcare financing systems are proportional or progressive, that is the higher the income, the higher the contribution. In his ''Benchmarks of fairness for health care reform in developing countries'', Norman Daniels writes:
The fundamental idea is that financing medical services, as opposed to access to them, should be according to ability to pay. (11) This idea can be traced back to political economists such as Adam Smith and John Stuart Mill. The latter wrote:
... all are thought to have done their part fairly when each has contributed according to his means, that is, has made an equal sacrifice for a common object. (12) The second prominent aspect is equity in the use of healthcare resources. In egalitarian political theories healthcare is regarded as a special good, and equal access to healthcare is more or less regarded as a human right. This way of thinking goes back at least to Aristotle, who wrote that good health is necessary for a good life. In so far as healthcare is necessary for good health, there is good reason to be concerned about its distribution.
Trivedi has recently published an analysis of healthcare utilization patterns in Vietnam, based on the Living Standards Survey Data from 1997 -98 (13) . One result is a strong positive relation between income and the use of both inpatient and outpatient care as provided at public hospitals. Both self-medication and commune health centres are inferior goods, so that demand for them declines with rising household incomes. These results are consistent with the view that both self-medication and commune health centres are low-quality and risky forms of healthcare (13) . Thus, in contrast with high-income countries, public healthcare is the option preferred by the upper class while the lower classes are forced, as a consequence of limited economic resources, to use self-medication and/or private providers.
The road to more equitable healthcare financing systems seems to be increased tax financing and/or community-rated insurance. Both these methods are based on the principle of ability-to-pay and can also be given a progressive design. A financing reform will also change people's access to healthcare, and the use will be more a reflection of people's need than people's economic resources.
One common objection against pre-paid healthcare is the occurrence of moral hazard. This concept describes a tendency to changed patient behaviour when they are covered by health insurance. Health insurance, or taxes, may take away incentives for both physicians and patients to choose cheap drugs since the ''third party'' pays. The classical remedy against moral hazard is co-insurance, but the co-insurance rate is a controversial issue. An excessive rate can exclude people from care, while a minimal rate can endanger a tax or insurance system based on limited resources. Thus the right balance between prepayment and co-insurance is important to find.
What are the major research questions in this scenario? This brief analysis of the healthcare system in Vietnam points out some key issues for further research:
1. More reliable basic information regarding health, living standards, incomes, consumption, etc. at the household level is needed. 2. How can effective systems be developed for assessing incomes and collecting taxes? In developed countries, it is taken for granted that the government can decide on taxes and collect (most of) them. In developing countries is it normally very difficult to assess incomes and collect taxes. 3. An overwhelming majority of economists and other analysts judge out-of-pocket payment as the worst health-financing option. A very pressing question is thus how to transform actual out-ofpocket payments into taxes or community-based insurance schemes. Likely approaches are smallscale interventions in combination with careful multidisciplinary evaluations to elucidate the best strategies. 4. The most cost-effective health interventions must be identified and implemented. Our knowledge about different interventions and their costeffectiveness in a population perspective is very limited, even in high-income countries. It is difficult to find a single cost-utility analysis successfully accomplished in a developing country (14) . 5. Wages in healthcare tend to be very low in developing countries, which probably increases the incentives for supplier-induced demand, not least in the pharmaceutical sector. Higher wages will add to the financial burden in public healthcare but can in return increase efficiency by means of reduced ''unnecessary'' or even harmful consumption of drugs. The trade-offs between increased wages and efficiency gains have to be investigated. 6 . Proper regulations must be developed, implemented, and supervised. The developed state intervenes in a number of ways in order to influence the behaviour of both patients and providers.
